- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
January 3rd, 2007
The device uses iron-based nanoparticles that are sensitive to substances such as oxygen and glucose.
Changes in the levels of these molecules can reflect whether a tumour is growing or shrinking. When the substances are detected, they bind to the nanoparticles and cause them to clump together. Doctors can then detect the clumps with a simple MRI scan.
|Related News Press|
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015
Nanospiked bacteria are the brightest hard X-ray emitters July 2nd, 2015
Engineering the world’s smallest nanocrystal July 2nd, 2015
Producing spin-entangled electrons July 2nd, 2015